MetaVia Inc. (MTVA)
MTVA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.43
-1.38% on the day
Market cap
$9.4M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | MTVA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001638287 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-02 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEF 14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 631 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| KPTI | Karyopharm Therapeutics Inc. | $0.4274 | -15.38% | $9.7M |
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| TOVX | Theriva Biologics Inc. | $0.2157 | -1.69% | $9.9M |
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
| ADIL | Adial Pharmaceuticals Inc | $3.29 | -6.00% | $8.6M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier